A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).
A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or AQUAPORIN-2; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.
Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).
A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
Aquaporin 2 is a water-specific channel protein that is expressed in KIDNEY COLLECTING DUCTS. The translocation of aquaporin 2 to the apical PLASMA MEMBRANE is regulated by VASOPRESSIN, and MUTATIONS in AQP2 have been implicated in a variety of kidney disorders including DIABETES INSIPIDUS.
Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.
A mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus.
Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS.
Carrier proteins for OXYTOCIN and VASOPRESSIN. They are polypeptides of about 10-kDa, synthesized in the HYPOTHALAMUS. Neurophysin I is associated with oxytocin and neurophysin II is associated with vasopressin in their respective precursors and during transportation down the axons to the neurohypophysis (PITUITARY GLAND, POSTERIOR).
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.
Aquaporin 6 is an aquaglyceroporin that is found primarily in KIDNEY COLLECTING DUCTS. AQP6 protein functions as an anion-selective channel.
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Neural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the hypothalamic infundibulum of the PITUITARY STALK, to the posterior lobe of the pituitary gland.
Neoplastic, inflammatory, infectious, and other diseases of the hypothalamus. Clinical manifestations include appetite disorders; AUTONOMIC NERVOUS SYSTEM DISEASES; SLEEP DISORDERS; behavioral symptoms related to dysfunction of the LIMBIC SYSTEM; and neuroendocrine disorders.
The ability of the kidney to excrete in the urine high concentrations of solutes from the blood plasma.
A class of porins that allow the passage of WATER and other small molecules across CELL MEMBRANES.
Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
Excessive amount of sodium in the blood. (Dorland, 27th ed)
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
A drive stemming from a physiological need for WATER.
Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve (see OPTIC NERVE NEOPLASMS), and pituitary gland (see PITUITARY NEOPLASMS). Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051)
A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.
An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
The withholding of water in a structured experimental situation.
A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD (first letter of each word) and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.
A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.
Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.
A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
A hereditary or acquired form of generalized dysfunction of the PROXIMAL KIDNEY TUBULE without primary involvement of the KIDNEY GLOMERULUS. It is usually characterized by the tubular wasting of nutrients and salts (GLUCOSE; AMINO ACIDS; PHOSPHATES; and BICARBONATES) resulting in HYPOKALEMIA; ACIDOSIS; HYPERCALCIURIA; and PROTEINURIA.
The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent.
The balance of fluid in the BODY FLUID COMPARTMENTS; total BODY WATER; BLOOD VOLUME; EXTRACELLULAR SPACE; INTRACELLULAR SPACE, maintained by processes in the body that regulate the intake and excretion of WATER and ELECTROLYTES, particularly SODIUM and POTASSIUM.
An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER.
Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla.
Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.
A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
PROCEDURES that use NEUROENDOSCOPES for disease diagnosis and treatment. Neuroendoscopy, generally an integration of the neuroendoscope with a computer-assisted NEURONAVIGATION system, provides guidance in NEUROSURGICAL PROCEDURES.
A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.
Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.
A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.
Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.
Examinations that evaluate functions of the pituitary gland.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
The condition that results from excessive loss of water from a living organism.
Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
The consumption of liquids.
Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.
A group of inherited kidney disorders characterized by the abnormally elevated levels of AMINO ACIDS in URINE. Genetic mutations of transport proteins result in the defective reabsorption of free amino acids at the PROXIMAL RENAL TUBULES. Renal aminoaciduria are classified by the specific amino acid or acids involved.
Aquaporin 3 is an aquaglyceroporin that is expressed in the KIDNEY COLLECTING DUCTS and is constitutively localized at the basolateral MEMBRANE.
Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS.
Glucose in blood.
Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.
Discharge of URINE, liquid waste processed by the KIDNEY, from the body.
An antihyperlipoproteinemic agent and uricosuric agent.
Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.
The response of cells in sensing a difference in OSMOTIC PRESSURE between the inside and outside of the cell. This response includes signaling from osmotic sensors to activate transcription factors, which in turn regulate the expression of osmocompensatory genes, all functioning to maintain CELL VOLUME and the water concentration inside the cells.
A condition resulting from the excessive retention of water with sodium depletion.
Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.
Inorganic compounds that contain lithium as an integral part of the molecule.
Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).

Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. (1/69)

OBJECTIVES: We retrospectively reviewed 5 patients with neurosarcoidosis, who all presented with central diabetes insipidus and hypogonadism. DESIGN: This was a single-centre, retrospective analysis of 5 cases with a minimum follow-up of 2 years. METHODS: Case analysis included clinical, biochemical, and endocrinological evaluation and frequent CT/MRI scans of involved organs as primary evaluation and in response to immunosuppressive therapy. RESULT: Neurosarcoidosis was diagnosed in all patients. Two patients had no proven extracerebral manifestation and had a stable disease over 3 and 5 years. One patient showed deterioration with corticosteroids alone but partial remission after additional cyclophosphamide. Pituitary dysfunction remained unchanged in all patients, despite total clinical and radiological remission in two patients. However, one of these patients died of acute granulomatous meningoencephalitis after two years of follow-up. CONCLUSION: Although the presenting symptoms of neurosarcoidosis may vary, the occurrence of central diabetes insipidus associated with typical radiological features is suggestive of neurosarcoidosis. However, there is an increasing number of case reports on lymphocytic hypophysitis. Without the bioptic diagnosis, the differentiation between potentially lethal isolated neurosarcoidosis and lymphocytic hypophysitis is difficult. These cases demonstrate the difficulties in diagnosing neurosarcoidosis and reflect experiences with follow-up parameters.  (+info)

Central diabetes insipidus in children and young adults. (2/69)

BACKGROUND: Central diabetes insipidus is rare in children and young adults, and up to 50 percent of cases are idiopathic. The clinical presentation and the long-term course of this disorder are largely undefined. METHODS: We studied all 79 patients with central diabetes insipidus who were seen at four pediatric endocrinology units between 1970 and 1996. There were 37 male and 42 female patients whose median age at diagnosis was 7.0 years (range, 0.1 to 24.8). All patients underwent magnetic resonance imaging (MRI) and periodic studies of anterior pituitary function. The median duration of follow-up was 7.6 years (range, 1.6 to 26.2). RESULTS: The causes of the central diabetes insipidus were Langerhans-cell histiocytosis in 12 patients, an intracranial tumor in 18 patients, a skull fracture in 2 patients, and autoimmune polyendocrinopathy in 1 patient; 5 patients had familial disease. The cause was considered to be idiopathic in 41 patients (52 percent). In 74 patients (94 percent) the posterior pituitary was not hyperintense on the first MRI scan obtained, and 29 patients (37 percent) had thickening of the pituitary stalk. Eighteen patients had changes in the thickness of the pituitary stalk over time, ranging from normalization (six patients) or a decrease in thickness (one patient) to further thickening (seven patients) or thickening of a previously normal stalk (four patients). Anterior pituitary hormone deficiencies, primarily growth hormone deficiency, were documented in 48 patients (61 percent) a median of 0.6 year (range, 0.1 to 18.0) after the onset of central diabetes insipidus. CONCLUSIONS: Most children and young adults with acquired central diabetes insipidus have abnormal findings on MRI scans of the head, which may change over time, and at least half have anterior pituitary hormone deficiencies during follow-up.  (+info)

Effects of various mutations in the neurophysin/glycopeptide portion of the vasopressin gene on vasopressin expression in vitro. (3/69)

The vasopressin gene encodes three polypeptides besides the signal peptide: vasopressin, neurophysin II (neurophysin), and the carboxy-terminal glycopeptide (glycopeptide). Although the function of vasopressin is well characterized, those of the latter two are not completely understood. In the present study, we investigated the effects of various mutations within the neurophysin/glycopeptide portion of the vasopressin gene on vasopressin secretion in vitro, to clarify the role of each peptide in vasopressin biosynthesis. Expression vectors containing the vasopressin gene, either wild-type or various mutants, were transiently transfected into AtT20 cells, which are known to have the enzymes necessary for the proper processing of the vasopressin precursor protein. The amount of vasopressin secreted into the culture medium was estimated by specific radioimmunoassay. Variable degrees of decreased vasopressin secretion were observed with mutant vasopressin genes harboring deletions or amino acid substitutions in neurophysin. The naturally-occurring frame-shift mutation in the hereditary diabetes insipidus (Brattleboro) rat completely eliminated vasopressin expression. In contrast, a missense mutation found in patients with familial neurogenic diabetes insipidus only partially decreased vasopressin secretion. Finally, the mutant vasopressin gene lacking the N-linked glycosylation site in glycopeptide had no effect on vasopressin expression. Our data suggest that 1) intact neurophysin is not indispensable for vasopressin expression, although an altered structure of neurophysin significantly affects the secretion of the hormone; 2) the pathogenesis of diabetes insipidus with the two naturally-occurring mutations found in the rat (Brattleboro rat) and human (familial central diabetes insipidus) seem to be different; and 3) glycosylation of the carboxy-terminal glycopeptide is not essential for the expression of vasopressin.  (+info)

A clinical feature of hyperlipidemia in patients with central diabetes insipidus. (4/69)

In this study, we analyzed plasma lipid and lipoprotein levels before and after treatment with 1-desamino-8-D-arginine vasopressin (DDAVP) in subjects with partial and complete central diabetes insipidus (DI) in order to determine how a shortage and supplement of this hormone affect plasma lipid metabolism. The subjects consisted of 6 patients with partial and 6 with complete central DI. After treatment with DDAVP through nasal cavity, plasma total cholesterol (TC) level did not decrease either in complete or partial form. Plasma triglyceride (TG) levels decreased from 306+/-175 mg/dl to 198+/-91 (35% decrease, p=0.027) in complete form, while TG did not change significantly in partial form. A detailed investigation of plasma lipoprotein metabolism during treatment with DDAVP was carried out in 3 of the 6 subjects with complete form of DI. Lipoprotein lipase activity and mass in post-heparin plasma from those three subjects tended to increase after treatment with DDAVP, along with the complete disappearance of an unusual lipoprotein between low density lipoprotein (LDL) and very low density lipoprotein (VLDL) as analyzed by polyacrylamide gel electrophoresis. These results suggest that the DDAVP treatment has a favorable effect on lipid and lipoprotein metabolism, especially triglyceride-rich lipoproteins, either directly or through modifying factors contributing to lipid metabolism.  (+info)

Pituitary tumors: pathophysiology, clinical manifestations and management. (5/69)

Pituitary tumors are frequently encountered intracranial neoplasms. They present with a variety of clinical manifestations that include symptoms and signs of excessive hormone secretion by the tumor, signs of hormone deficits by the normal pituitary gland and others related to expansion of the tumor mass and the resulting compression of surrounding structures such as the optic chiasm and cranial nerves. Advances in molecular biology, immunocytochemical staining and imaging, and the introduction of new treatment options have improved our understanding of the natural history of these adenomas and their management. Available treatments include surgical, medical and radiation therapy. Although the primary treatment for each tumor type may vary, it is important to consider all available options and select the most applicable for that patient. The interaction of all members of management team, including the primary care provider, the endocrinologist and the neurosurgeon in selecting the treatment course can only improve therapeutic outcome. Regardless of the initial choice of treatment,follow-up of all patients should be maintained indefinitely. The managing physician should be familiar with the natural history and long-term complications of pituitary adenomas, and with the side effects of treatments given over the years.  (+info)

MR imaging of central diabetes insipidus: a pictorial essay. (6/69)

Central diabetes insipidus (DI) can be the outcome of a number of diseases that affect the hypothalamic-neurohypophyseal axis. The causes of the condition can be classified as traumatic, inflammatory, or neoplastic. Traumatic causes include postoperative sella or transection of the pituitary stalk, while infectious or inflammatory causes include meningitis, lymphocytic hypophysitis, and granulomatous inflammations such as sarcoidosis and Wegener's granulomatosis. Various neoplastic conditions such as germinoma, Langerhans cell histiocytosis, metastasis, leukemic infiltration, lymphoma, teratoma, pituitary adenoma, craniopharyngioma, Rathke cleft cyst, hypothalamic glioma, and meningioma are also causes of central DI. In affected patients, careful analysis of these MR imaging features and correlation with the clinical manifestations can allow a more specific diagnosis, which is essential for treatment.  (+info)

Transient central diabetes insipidus in pregnancy with a peculiar change in signal intensity on T1-weighted magnetic resonance images. (7/69)

A 38-year-old woman was admitted with severe thirst and polyuria at 31 weeks' gestation. The plasma concentration of vasopressin (AVP) was very low (0.73 pg/ml) under conditions of high plasma osmolality (316 mOsm/ kg). T1-weighted magnetic resonance (MR) images revealed enlargement of the pituitary posterior lobe with absence of the hyperintense signal. After delivery, restoration of the hyperintense signal was demonstrated. This depletion-repletion process, which reflects the decrease and increase in amount of neurosecretory granules, is recognized in the case of transient central diabetes insipidus during pregnancy. We consider that an increase in cystine-aminopeptidase (CAP) activity is implicated in the pathogenesis.  (+info)

Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment. (8/69)

We studied the efficacy and safety of oral 1-deamino-8-D-arginine-vasopressin (DDAVP) tablets in 9 patients, aged 17-36 years, with central diabetes insipidus (DI). The tablet contained 100 microg of desmopressin acetate. Maximum plasma concentration was obtained at 90 min after a single oral administration of 100 microg DDAVP with a mean plasma level of 14.7 +/- 5.4 (range: 5.3-50.9) pg/ml. The onset of action was observed 2 h after oral administration, while the maximum effect was obtained at 4 h. Mean urine volume in patients decreased significantly from 402 +/- 52 to 26 +/- 3 ml/hr and urine osmolality increased from 91 +/- 8 to 732 +/- 21 mosm/kg at 4 h after the intake of oral DDAVP. Plasma osmolality level and serum sodium concentration remained unchanged throughout the study. Long-term treatment for 5 years with oral DDAVP resulted in control of diuresis in 8 of the 9 patients. The average oral DDAVP dose required to obtain this control was 19 +/- 2 (range: 15-30) times more than that of prior intranasal treatment. No adverse effects were observed during this follow-up period. These results indicate that oral DDAVP is a safe therapeutic agent that may be a good alternative treatment of central DI, particularly in patients who have chronic rhinitis and visual disturbances.  (+info)

Diabetes Insipidus is a medical condition characterized by the excretion of large amounts of dilute urine (polyuria) and increased thirst (polydipsia). It is caused by a deficiency in the hormone vasopressin (also known as antidiuretic hormone or ADH), which regulates the body's water balance.

In normal physiology, vasopressin is released from the posterior pituitary gland in response to an increase in osmolality of the blood or a decrease in blood volume. This causes the kidneys to retain water and concentrate the urine. In Diabetes Insipidus, there is either a lack of vasopressin production (central diabetes insipidus) or a decreased response to vasopressin by the kidneys (nephrogenic diabetes insipidus).

Central Diabetes Insipidus can be caused by damage to the hypothalamus or pituitary gland, such as from tumors, trauma, or surgery. Nephrogenic Diabetes Insipidus can be caused by genetic factors, kidney disease, or certain medications that interfere with the action of vasopressin on the kidneys.

Treatment for Diabetes Insipidus depends on the underlying cause. In central diabetes insipidus, desmopressin, a synthetic analogue of vasopressin, can be administered to replace the missing hormone. In nephrogenic diabetes insipidus, treatment may involve addressing the underlying kidney disease or adjusting medications that interfere with vasopressin action. It is important for individuals with Diabetes Insipidus to maintain adequate hydration and monitor their fluid intake and urine output.

Neurogenic diabetes insipidus is a condition characterized by the production of large amounts of dilute urine (polyuria) and increased thirst (polydipsia) due to deficiency of antidiuretic hormone (ADH), also known as vasopressin, which is produced by the hypothalamus and stored in the posterior pituitary gland.

Neurogenic diabetes insipidus can occur when there is damage to the hypothalamus or pituitary gland, leading to a decrease in ADH production or release. Causes of neurogenic diabetes insipidus include brain tumors, head trauma, surgery, meningitis, encephalitis, and autoimmune disorders.

In this condition, the kidneys are unable to reabsorb water from the urine due to the lack of ADH, resulting in the production of large volumes of dilute urine. This can lead to dehydration, electrolyte imbalances, and other complications if not properly managed. Treatment typically involves replacing the missing ADH with a synthetic hormone called desmopressin, which can be administered as a nasal spray, oral tablet, or injection.

Nephrogenic diabetes insipidus is a type of diabetes insipidus that occurs due to the inability of the kidneys to respond to the antidiuretic hormone (ADH), also known as vasopressin. This results in excessive thirst and the production of large amounts of dilute urine.

In nephrogenic diabetes insipidus, the problem lies in the kidney tubules, which fail to absorb water from the urine due to a defect in the receptors or channels that respond to ADH. This can be caused by genetic factors, certain medications, kidney diseases, and electrolyte imbalances.

Treatment for nephrogenic diabetes insipidus typically involves addressing the underlying cause, if possible, as well as managing symptoms through a low-salt diet, increased fluid intake, and medications that increase water reabsorption in the kidneys.

Polyuria is a medical term that describes the production of large volumes of urine, typically defined as exceeding 2.5-3 liters per day in adults. This condition can lead to frequent urination, sometimes as often as every one to two hours, and often worsens during the night (nocturia). Polyuria is often a symptom of an underlying medical disorder such as diabetes mellitus or diabetes insipidus, rather than a disease itself. Other potential causes include kidney diseases, heart failure, liver cirrhosis, and certain medications. Proper diagnosis and treatment of the underlying condition are essential to manage polyuria effectively.

Desmopressin, also known as 1-deamino-8-D-arginine vasopressin (dDAVP), is a synthetic analogue of the natural hormone arginine vasopressin. It is commonly used in medical practice for the treatment of diabetes insipidus, a condition characterized by excessive thirst and urination due to lack of antidiuretic hormone (ADH).

Desmopressin works by binding to V2 receptors in the kidney, which leads to increased water reabsorption and reduced urine production. It also has some effect on V1 receptors, leading to vasoconstriction and increased blood pressure. However, its primary use is for its antidiuretic effects.

In addition to its use in diabetes insipidus, desmopressin may also be used to treat bleeding disorders such as hemophilia and von Willebrand disease, as it can help to promote platelet aggregation and reduce bleeding times. It is available in various forms, including nasal sprays, injectable solutions, and oral tablets or dissolvable films.

Aquaporin 2 (AQP2) is a type of aquaporin, which is a water channel protein found in the membranes of cells. Specifically, AQP2 is located in the principal cells of the collecting ducts in the kidneys. It plays a crucial role in regulating water reabsorption and urine concentration by facilitating the movement of water across the cell membrane in response to the hormone vasopressin (also known as antidiuretic hormone). When vasopressin binds to receptors on the cell surface, it triggers a cascade of intracellular signals that lead to the translocation of AQP2 water channels from intracellular vesicles to the apical membrane. This increases the permeability of the apical membrane to water, allowing for efficient reabsorption of water and concentration of urine. Dysfunction in AQP2 has been implicated in various kidney disorders, such as nephrogenic diabetes insipidus.

Pituitary diseases refer to a group of conditions that affect the pituitary gland, a small endocrine gland located at the base of the brain. The pituitary gland is responsible for producing and secreting several important hormones that regulate various bodily functions, including growth and development, metabolism, stress response, and reproduction.

Pituitary diseases can be classified into two main categories:

1. Pituitary tumors: These are abnormal growths in or around the pituitary gland that can affect its function. Pituitary tumors can be benign (non-cancerous) or malignant (cancerous), and they can vary in size. Some pituitary tumors produce excess hormones, leading to a variety of symptoms, while others may not produce any hormones but can still cause problems by compressing nearby structures in the brain.
2. Pituitary gland dysfunction: This refers to conditions that affect the normal function of the pituitary gland without the presence of a tumor. Examples include hypopituitarism, which is a condition characterized by decreased production of one or more pituitary hormones, and Sheehan's syndrome, which occurs when the pituitary gland is damaged due to severe blood loss during childbirth.

Symptoms of pituitary diseases can vary widely depending on the specific condition and the hormones that are affected. Treatment options may include surgery, radiation therapy, medication, or a combination of these approaches.

I'm sorry for any confusion, but "Rats, Brattleboro" is not a recognized medical term or condition. It seems like it could be a nonsensical phrase or a reference to something specific, such as a place (Brattleboro, a town in Vermont) and an exclamation of frustration or surprise ("rats"). If you're referring to a specific medical condition or concept, please provide more context so I can give you a more accurate and helpful response.

Vasopressin receptors are a type of G protein-coupled receptor that bind to and are activated by the hormone vasopressin (also known as antidiuretic hormone or ADH). There are two main types of vasopressin receptors, V1 and V2.

V1 receptors are found in various tissues throughout the body, including vascular smooth muscle, heart, liver, and kidney. Activation of V1 receptors leads to vasoconstriction (constriction of blood vessels), increased heart rate and force of heart contractions, and release of glycogen from the liver.

V2 receptors are primarily found in the kidney's collecting ducts. When activated, they increase water permeability in the collecting ducts, allowing for the reabsorption of water into the bloodstream and reducing urine production. This helps to regulate fluid balance and maintain normal blood pressure.

Abnormalities in vasopressin receptor function can contribute to various medical conditions, including hypertension, heart failure, and kidney disease.

Antidiuretic agents are medications or substances that reduce the amount of urine produced by the body. They do this by increasing the reabsorption of water in the kidneys, which leads to a decrease in the excretion of water and solutes in the urine. This can help to prevent dehydration and maintain fluid balance in the body.

The most commonly used antidiuretic agent is desmopressin, which works by mimicking the action of a natural hormone called vasopressin (also known as antidiuretic hormone or ADH). Vasopressin is produced by the pituitary gland and helps to regulate water balance in the body. When the body's fluid levels are low, vasopressin is released into the bloodstream, where it causes the kidneys to reabsorb more water and produce less urine.

Antidiuretic agents may be used to treat a variety of medical conditions, including diabetes insipidus (a rare disorder that causes excessive thirst and urination), bedwetting in children, and certain types of headaches. They may also be used to manage fluid balance in patients with kidney disease or heart failure.

It is important to use antidiuretic agents only under the supervision of a healthcare provider, as they can have side effects and may interact with other medications. Overuse or misuse of these drugs can lead to water retention, hyponatremia (low sodium levels in the blood), and other serious complications.

Neurophysins are small protein molecules that are derived from the larger precursor protein, pro-neurophysin. They are synthesized in the hypothalamus of the brain and are stored in and released from neurosecretory granules, along with neurohypophysial hormones such as oxytocin and vasopressin.

Neurophysins serve as carrier proteins for these hormones, helping to stabilize them and facilitate their transport and release into the bloodstream. There are two main types of neurophysins, neurophysin I and neurophysin II, which are associated with oxytocin and vasopressin, respectively.

Neurophysins have been studied for their potential role in various physiological processes, including water balance, social behavior, and reproductive functions. However, their precise mechanisms of action and functional significance are still not fully understood.

Vasopressin, also known as antidiuretic hormone (ADH), is a hormone that helps regulate water balance in the body. It is produced by the hypothalamus and stored in the posterior pituitary gland. When the body is dehydrated or experiencing low blood pressure, vasopressin is released into the bloodstream, where it causes the kidneys to decrease the amount of urine they produce and helps to constrict blood vessels, thereby increasing blood pressure. This helps to maintain adequate fluid volume in the body and ensure that vital organs receive an adequate supply of oxygen-rich blood. In addition to its role in water balance and blood pressure regulation, vasopressin also plays a role in social behaviors such as pair bonding and trust.

Chlorpropamide is a type of oral anti-diabetic drug known as a sulfonylurea, which is used to lower blood glucose levels in people with type 2 diabetes. It works by stimulating the release of insulin from the pancreas and increasing the sensitivity of peripheral tissues to insulin.

Here's the medical definition:

Chlorpropamide: A first-generation sulfonylurea medication used in the management of type 2 diabetes mellitus. It acts by stimulating the release of insulin from the pancreatic beta cells and increasing peripheral tissue sensitivity to insulin. Chlorpropamide has a longer duration of action than other sulfonylureas, with a peak effect at around 6-12 hours after administration. Common side effects include hypoglycemia, weight gain, and gastrointestinal symptoms such as nausea and diarrhea. It is important to monitor blood glucose levels regularly while taking chlorpropamide to avoid hypoglycemia.

Hypopituitarism is a medical condition characterized by deficient secretion of one or more hormones produced by the pituitary gland, a small endocrine gland located at the base of the brain. The pituitary gland controls several other endocrine glands in the body, including the thyroid, adrenals, and sex glands (ovaries and testes).

Hypopituitarism can result from damage to the pituitary gland due to various causes such as tumors, surgery, radiation therapy, trauma, or inflammation. In some cases, hypopituitarism may also be caused by a dysfunction of the hypothalamus, a region in the brain that regulates the pituitary gland's function.

The symptoms and signs of hypopituitarism depend on which hormones are deficient and can include fatigue, weakness, decreased appetite, weight loss, low blood pressure, decreased sex drive, infertility, irregular menstrual periods, intolerance to cold, constipation, thinning hair, dry skin, and depression.

Treatment of hypopituitarism typically involves hormone replacement therapy to restore the deficient hormones' normal levels. The type and dosage of hormones used will depend on which hormones are deficient and may require regular monitoring and adjustments over time.

Aquaporin 6 (AQP6) is a protein that functions as a water channel in the membranes of certain cells. It is a member of the aquaporin family, which are proteins that allow the selective transport of water and small solutes across biological membranes. Aquaporin 6 is primarily expressed in the kidney, where it is localized to the intracellular vesicles of intercalated cells in the collecting ducts. It is thought to play a role in acid-base balance and urine concentration by regulating the movement of water and hydrogen ions (protons) across cell membranes. Aquaporin 6 has also been found to be permeable to anions, making it unique among aquaporins. Additionally, AQP6 has been identified in other tissues such as the brain, lung, and testis, but its function in these tissues is not well understood.

Diabetes Mellitus, Type 1 is a chronic autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas, leading to an absolute deficiency of insulin. This results in an inability to regulate blood glucose levels, causing hyperglycemia (high blood sugar). Type 1 diabetes typically presents in childhood or early adulthood, although it can develop at any age. It is usually managed with regular insulin injections or the use of an insulin pump, along with monitoring of blood glucose levels and adjustments to diet and physical activity. Uncontrolled type 1 diabetes can lead to serious complications such as kidney damage, nerve damage, blindness, and cardiovascular disease.

Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is a hormone produced in the hypothalamus and stored in the posterior pituitary gland. It plays a crucial role in regulating water balance and blood pressure in the body.

AVP acts on the kidneys to promote water reabsorption, which helps maintain adequate fluid volume and osmotic balance in the body. It also constricts blood vessels, increasing peripheral vascular resistance and thereby helping to maintain blood pressure. Additionally, AVP has been shown to have effects on cognitive function, mood regulation, and pain perception.

Deficiencies or excesses of AVP can lead to a range of medical conditions, including diabetes insipidus (characterized by excessive thirst and urination), hyponatremia (low sodium levels in the blood), and syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Diabetes Mellitus is a chronic metabolic disorder characterized by elevated levels of glucose in the blood (hyperglycemia) due to absolute or relative deficiency in insulin secretion and/or insulin action. There are two main types: Type 1 diabetes, which results from the autoimmune destruction of pancreatic beta cells leading to insulin deficiency, and Type 2 diabetes, which is associated with insulin resistance and relative insulin deficiency.

Type 1 diabetes typically presents in childhood or young adulthood, while Type 2 diabetes tends to occur later in life, often in association with obesity and physical inactivity. Both types of diabetes can lead to long-term complications such as damage to the eyes, kidneys, nerves, and cardiovascular system if left untreated or not well controlled.

The diagnosis of diabetes is usually made based on fasting plasma glucose levels, oral glucose tolerance tests, or hemoglobin A1c (HbA1c) levels. Treatment typically involves lifestyle modifications such as diet and exercise, along with medications to lower blood glucose levels and manage associated conditions.

The posterior pituitary gland, also known as the neurohypophysis, is the posterior portion of the pituitary gland. It is primarily composed of nerve fibers that originate from the hypothalamus, a region of the brain. These nerve fibers release two important hormones: oxytocin and vasopressin (also known as antidiuretic hormone or ADH).

Oxytocin plays a role in social bonding, sexual reproduction, and childbirth. During childbirth, it stimulates uterine contractions to help facilitate delivery, and after birth, it helps to trigger the release of milk from the mother's breasts during breastfeeding.

Vasopressin, on the other hand, helps regulate water balance in the body by controlling the amount of water that is excreted by the kidneys. It does this by increasing the reabsorption of water in the collecting ducts of the kidney, which leads to a more concentrated urine and helps prevent dehydration.

Overall, the posterior pituitary gland plays a critical role in maintaining fluid balance, social bonding, and reproduction.

Hypothalamic diseases refer to conditions that affect the hypothalamus, a small but crucial region of the brain responsible for regulating many vital functions in the body. The hypothalamus helps control:

1. Body temperature
2. Hunger and thirst
3. Sleep cycles
4. Emotions and behavior
5. Release of hormones from the pituitary gland

Hypothalamic diseases can be caused by genetic factors, infections, tumors, trauma, or other conditions that damage the hypothalamus. Some examples of hypothalamic diseases include:

1. Hypothalamic dysfunction syndrome: A condition characterized by various symptoms such as obesity, sleep disturbances, and hormonal imbalances due to hypothalamic damage.
2. Kallmann syndrome: A genetic disorder that affects the development of the hypothalamus and results in a lack of sexual maturation and a decreased sense of smell.
3. Prader-Willi syndrome: A genetic disorder that causes obesity, developmental delays, and hormonal imbalances due to hypothalamic dysfunction.
4. Craniopharyngiomas: Tumors that develop near the pituitary gland and hypothalamus, often causing visual impairment, hormonal imbalances, and growth problems.
5. Infiltrative diseases: Conditions such as sarcoidosis or histiocytosis can infiltrate the hypothalamus, leading to various symptoms related to hormonal imbalances and neurological dysfunction.
6. Traumatic brain injury: Damage to the hypothalamus due to head trauma can result in various hormonal and neurological issues.
7. Infections: Bacterial or viral infections that affect the hypothalamus, such as encephalitis or meningitis, can cause damage and lead to hypothalamic dysfunction.

Treatment for hypothalamic diseases depends on the underlying cause and may involve medications, surgery, hormone replacement therapy, or other interventions to manage symptoms and improve quality of life.

Kidney concentrating ability refers to the capacity of the kidneys to increase the concentration of solutes, such as urea and minerals, and remove waste products while reabsorbing water to maintain fluid balance in the body. This is primarily regulated by the hormone vasopressin (ADH), which signals the collecting ducts in the nephrons of the kidneys to absorb more water, resulting in the production of concentrated urine. A decreased kidney concentrating ability may indicate a variety of renal disorders or diseases, such as diabetes insipidus or chronic kidney disease.

Aquaporins are a type of membrane protein that function as water channels, allowing the selective and efficient transport of water molecules across biological membranes. They play crucial roles in maintaining fluid homeostasis, regulating cell volume, and supporting various physiological processes in the body. In humans, there are 13 different aquaporin subtypes (AQP0 to AQP12) that have been identified, each with distinct tissue expression patterns and functions. Some aquaporins also facilitate the transport of small solutes such as glycerol and urea. Dysfunction or misregulation of aquaporins has been implicated in several pathological conditions, including neurological disorders, cancer, and water balance-related diseases.

"Renal agents" is not a standardized medical term with a single, widely accepted definition. However, in a general sense, renal agents could refer to medications or substances that have an effect on the kidneys or renal function. This can include drugs that are primarily used to treat kidney diseases or disorders (such as certain types of diuretics, ACE inhibitors, or ARBs), as well as chemicals or toxins that can negatively impact renal function if they are not properly eliminated from the body.

It's worth noting that the term "renal agent" is not commonly used in medical literature or clinical practice, and its meaning may vary depending on the context in which it is used. If you have any specific questions about a particular medication or substance and its effect on renal function, I would recommend consulting with a healthcare professional for more accurate information.

Hypernatremia is a medical condition characterized by an abnormally high concentration of sodium (na+) in the blood, specifically a serum sodium level greater than 145 mEq/L. Sodium is an essential electrolyte that helps regulate water balance in and around your cells. It's crucial for many body functions, including the maintenance of blood pressure, regulation of nerve and muscle function, and regulation of fluid balance.

Hypernatremia typically results from a deficit of total body water relative to solute, which can be caused by decreased water intake, increased water loss, or a combination of both. Common causes include dehydration due to severe vomiting or diarrhea, excessive sweating, burns, kidney diseases, and the use of certain medications such as diuretics.

Symptoms of hypernatremia can range from mild to severe and may include thirst, muscle weakness, lethargy, irritability, confusion, seizures, and in extreme cases, coma or even death. Treatment typically involves correcting the underlying cause and gradually rehydrating the individual with intravenous fluids to restore normal sodium levels.

Diabetes Mellitus, Type 2 is a metabolic disorder characterized by high blood glucose (or sugar) levels resulting from the body's inability to produce sufficient amounts of insulin or effectively use the insulin it produces. This form of diabetes usually develops gradually over several years and is often associated with older age, obesity, physical inactivity, family history of diabetes, and certain ethnicities.

In Type 2 diabetes, the body's cells become resistant to insulin, meaning they don't respond properly to the hormone. As a result, the pancreas produces more insulin to help glucose enter the cells. Over time, the pancreas can't keep up with the increased demand, leading to high blood glucose levels and diabetes.

Type 2 diabetes is managed through lifestyle modifications such as weight loss, regular exercise, and a healthy diet. Medications, including insulin therapy, may also be necessary to control blood glucose levels and prevent long-term complications associated with the disease, such as heart disease, nerve damage, kidney damage, and vision loss.

Thirst, also known as dry mouth or polydipsia, is a physiological need or desire to drink fluids to maintain fluid balance and hydration in the body. It is primarily regulated by the hypothalamus in response to changes in osmolality and volume of bodily fluids, particularly blood. Thirst can be triggered by various factors such as dehydration, excessive sweating, diarrhea, vomiting, fever, burns, certain medications, and medical conditions affecting the kidneys, adrenal glands, or other organs. It is a vital homeostatic mechanism to ensure adequate hydration and proper functioning of various bodily systems.

Hypothalamic neoplasms refer to tumors that originate in the hypothalamus, a small region of the brain that is located at the base of the brain and forms part of the limbic system. The hypothalamus plays a critical role in regulating many bodily functions, including hormone release, temperature regulation, hunger, thirst, sleep, and emotional behavior.

Hypothalamic neoplasms can be benign or malignant and can arise from various cell types within the hypothalamus, such as neurons, glial cells, or supportive tissue. These tumors can cause a variety of symptoms depending on their size, location, and rate of growth. Common symptoms include endocrine disorders (such as diabetes insipidus or precocious puberty), visual disturbances, headaches, behavioral changes, and cognitive impairment.

The diagnosis of hypothalamic neoplasms typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and sometimes biopsy or surgical removal of the tumor. Treatment options depend on the type, size, and location of the tumor but may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. Regular follow-up care is essential to monitor for recurrence or progression of the tumor.

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by the abnormal proliferation and accumulation of dendritic cells called Langerhans cells in various tissues and organs of the body. These cells are part of the immune system and normally help to fight infection. However, in LCH, an overactive immune response leads to the excessive buildup of these cells, forming granulomas that can damage organs and impair their function.

The exact cause of LCH is not fully understood, but it is thought to involve genetic mutations that lead to uncontrolled cell growth and division. The disorder can affect people of any age, although it is most commonly diagnosed in children under the age of 15.

LCH can affect a single organ or multiple organs, depending on the severity and extent of the disease. Commonly affected sites include the bones, skin, lymph nodes, lungs, liver, spleen, and pituitary gland. Symptoms vary widely depending on the location and severity of the disease, but may include bone pain, rashes, fatigue, fever, weight loss, cough, and difficulty breathing.

Treatment for LCH depends on the extent and severity of the disease. In mild cases, observation and monitoring may be sufficient. More severe cases may require chemotherapy, radiation therapy, or surgery to remove affected tissues. In some cases, immunosuppressive drugs or targeted therapies that target specific genetic mutations may be used.

Overall, LCH is a complex and poorly understood disorder that requires careful evaluation and management by a team of medical specialists. While the prognosis for patients with LCH has improved in recent years, some cases can be life-threatening or lead to long-term complications.

Diuresis is a medical term that refers to an increased production of urine by the kidneys. It can occur as a result of various factors, including certain medications, medical conditions, or as a response to a physiological need, such as in the case of dehydration. Diuretics are a class of drugs that promote diuresis and are often used to treat conditions such as high blood pressure, heart failure, and edema.

Diuresis can be classified into several types based on its underlying cause or mechanism, including:

1. Osmotic diuresis: This occurs when the kidneys excrete large amounts of urine in response to a high concentration of solutes (such as glucose) in the tubular fluid. The high osmolarity of the tubular fluid causes water to be drawn out of the bloodstream and into the urine, leading to an increase in urine output.
2. Forced diuresis: This is a medical procedure in which large amounts of intravenous fluids are administered to promote diuresis. It is used in certain clinical situations, such as to enhance the excretion of toxic substances or to prevent kidney damage.
3. Natriuretic diuresis: This occurs when the kidneys excrete large amounts of sodium and water in response to the release of natriuretic peptides, which are hormones that regulate sodium balance and blood pressure.
4. Aquaresis: This is a type of diuresis that occurs in response to the ingestion of large amounts of water, leading to dilute urine production.
5. Pathological diuresis: This refers to increased urine production due to underlying medical conditions such as diabetes insipidus or pyelonephritis.

It is important to note that excessive diuresis can lead to dehydration and electrolyte imbalances, so it should be monitored carefully in clinical settings.

Water deprivation is a condition that occurs when an individual is deliberately or unintentionally not given access to adequate water for a prolonged period. This can lead to dehydration, which is the excessive loss of body water and electrolytes. In severe cases, water deprivation can result in serious health complications, including seizures, kidney damage, brain damage, coma, and even death. It's important to note that water is essential for many bodily functions, including maintaining blood pressure, regulating body temperature, and removing waste products from the body. Therefore, it's crucial to stay hydrated by drinking an adequate amount of water each day.

Chlorothiazide is a medication that belongs to a class of diuretics known as thiazide diuretics. It works by increasing the excretion of salt and water from the body through urine, which helps to reduce blood pressure and decrease edema (swelling). Chlorothiazide is used to treat hypertension (high blood pressure), heart failure, and edema caused by various medical conditions.

The medical definition of Chlorothiazide is:

A thiazide diuretic drug used in the treatment of hypertension, heart failure, and edema. It acts by inhibiting the reabsorption of sodium and chloride ions in the distal convoluted tubule of the nephron, leading to increased excretion of salt and water in the urine. Chlorothiazide has a rapid onset of action and a short duration of effect, making it useful for acute situations requiring prompt diuresis. It is available in oral and injectable forms.

Wolfram Syndrome is a rare, progressive, genetic disorder that affects multiple organ systems, particularly the eyes, brain, endocrine system, and hearing. It is characterized by the combination of several features including diabetes insipidus (DI), diabetes mellitus (DM), optic nerve atrophy, and various neurological symptoms. The onset of this syndrome typically occurs in childhood.

The two major types of Wolfram Syndrome are WFS1 and WFS2, with WFS1 being the most common form. They are caused by mutations in different genes (WFS1 and CISD2 respectively), both of which play a role in maintaining the health of cells in the body, particularly those in the pancreas, eyes, and ears.

The symptoms of Wolfram Syndrome can vary widely among affected individuals, but often include:
- Diabetes insipidus (DI): This is characterized by excessive thirst and urination due to problems with the body's regulation of fluids.
- Diabetes mellitus (DM): This type of diabetes results from issues with insulin production or usage, leading to high blood sugar levels.
- Optic nerve atrophy: This can cause vision loss, typically starting in early childhood and progressing over time.
- Neurological symptoms: These may include hearing loss, problems with balance and coordination, difficulty swallowing, and neuropsychiatric issues such as depression and anxiety.

Currently, there is no cure for Wolfram Syndrome, and treatment primarily focuses on managing the individual symptoms of the disorder.

The Sella Turcica, also known as the Turkish saddle, is a depression or fossa in the sphenoid bone located at the base of the skull. It forms a housing for the pituitary gland, which is a small endocrine gland often referred to as the "master gland" because it controls other glands and makes several essential hormones. The Sella Turcica has a saddle-like shape, with its anterior and posterior clinoids forming the front and back of the saddle, respectively. This region is of significant interest in neuroimaging and clinical settings, as various conditions such as pituitary tumors or other abnormalities may affect the size, shape, and integrity of the Sella Turcica.

Central nervous system (CNS) cysts are abnormal fluid-filled sacs that develop in the brain or spinal cord. These cysts can be congenital, meaning they are present at birth and develop as a result of abnormal embryonic development, or they can be acquired later in life due to injury, infection, or disease.

CNS cysts can vary in size and may cause symptoms depending on their location and the amount of pressure they place on surrounding brain or spinal cord tissue. Symptoms may include headaches, seizures, weakness, numbness, or difficulty with coordination and balance. In some cases, CNS cysts may not cause any symptoms and may be discovered incidentally during imaging studies performed for other reasons.

There are several types of CNS cysts, including:

1. Arachnoid cysts: These are the most common type of CNS cyst and occur between the layers of the arachnoid membrane that covers the brain and spinal cord.
2. Colloid cysts: These cysts typically develop at the junction of the third and fourth ventricles in the brain and can obstruct the flow of cerebrospinal fluid (CSF), leading to increased intracranial pressure.
3. Ependymal cysts: These cysts arise from the ependymal cells that line the ventricular system of the brain and can cause symptoms by compressing surrounding brain tissue.
4. Neuroglial cysts: These cysts are composed of glial cells, which support and protect nerve cells in the CNS.
5. Pineal cysts: These cysts develop in the pineal gland, a small endocrine gland located near the center of the brain.

Treatment for CNS cysts depends on their size, location, and symptoms. In some cases, observation and monitoring may be all that is necessary. However, if the cyst is causing significant symptoms or is at risk of rupturing or obstructing CSF flow, surgical intervention may be required to remove or reduce the size of the cyst.

A craniopharyngioma is a type of brain tumor that develops near the pituitary gland, which is a small gland located at the base of the brain. These tumors arise from remnants of Rathke's pouch, an embryonic structure involved in the development of the pituitary gland.

Craniopharyngiomas are typically slow-growing and benign (non-cancerous), but they can still cause significant health problems due to their location. They can compress nearby structures such as the optic nerves, hypothalamus, and pituitary gland, leading to symptoms like vision loss, hormonal imbalances, and cognitive impairment.

Treatment for craniopharyngiomas usually involves surgical removal of the tumor, followed by radiation therapy in some cases. Regular follow-up with a healthcare team is essential to monitor for recurrence and manage any long-term effects of treatment.

Diabetes complications refer to a range of health issues that can develop as a result of poorly managed diabetes over time. These complications can affect various parts of the body and can be classified into two main categories: macrovascular and microvascular.

Macrovascular complications include:

* Cardiovascular disease (CVD): People with diabetes are at an increased risk of developing CVD, including coronary artery disease, peripheral artery disease, and stroke.
* Peripheral arterial disease (PAD): This condition affects the blood vessels that supply oxygen and nutrients to the limbs, particularly the legs. PAD can cause pain, numbness, or weakness in the legs and may increase the risk of amputation.

Microvascular complications include:

* Diabetic neuropathy: This is a type of nerve damage that can occur due to prolonged high blood sugar levels. It commonly affects the feet and legs, causing symptoms such as numbness, tingling, or pain.
* Diabetic retinopathy: This condition affects the blood vessels in the eye and can cause vision loss or blindness if left untreated.
* Diabetic nephropathy: This is a type of kidney damage that can occur due to diabetes. It can lead to kidney failure if not managed properly.

Other complications of diabetes include:

* Increased risk of infections, particularly skin and urinary tract infections.
* Slow healing of wounds, which can increase the risk of infection and amputation.
* Gum disease and other oral health problems.
* Hearing impairment.
* Sexual dysfunction.

Preventing or managing diabetes complications involves maintaining good blood sugar control, regular monitoring of blood glucose levels, following a healthy lifestyle, and receiving routine medical care.

Fanconi syndrome is a medical condition that affects the proximal tubules of the kidneys. These tubules are responsible for reabsorbing various substances, such as glucose, amino acids, and electrolytes, back into the bloodstream after they have been filtered through the kidneys.

In Fanconi syndrome, there is a defect in the reabsorption process, causing these substances to be lost in the urine instead. This can lead to a variety of symptoms, including:

* Polyuria (excessive urination)
* Polydipsia (excessive thirst)
* Dehydration
* Metabolic acidosis (an imbalance of acid and base in the body)
* Hypokalemia (low potassium levels)
* Hypophosphatemia (low phosphate levels)
* Vitamin D deficiency
* Rickets (softening and weakening of bones in children) or osteomalacia (softening of bones in adults)

Fanconi syndrome can be caused by a variety of underlying conditions, including genetic disorders, kidney diseases, drug toxicity, and heavy metal poisoning. Treatment typically involves addressing the underlying cause, as well as managing symptoms such as electrolyte imbalances and acid-base disturbances.

Osmolar concentration is a measure of the total number of solute particles (such as ions or molecules) dissolved in a solution per liter of solvent (usually water), which affects the osmotic pressure. It is expressed in units of osmoles per liter (osmol/L). Osmolarity and osmolality are related concepts, with osmolarity referring to the number of osmoles per unit volume of solution, typically measured in liters, while osmolality refers to the number of osmoles per kilogram of solvent. In clinical contexts, osmolar concentration is often used to describe the solute concentration of bodily fluids such as blood or urine.

Water-electrolyte balance refers to the regulation of water and electrolytes (sodium, potassium, chloride, bicarbonate) in the body to maintain homeostasis. This is crucial for various bodily functions such as nerve impulse transmission, muscle contraction, fluid balance, and pH regulation. The body maintains this balance through mechanisms that control water intake, excretion, and electrolyte concentration in various body fluids like blood and extracellular fluid. Disruptions in water-electrolyte balance can lead to dehydration or overhydration, and imbalances in electrolytes can cause conditions such as hyponatremia (low sodium levels) or hyperkalemia (high potassium levels).

Lithium is not a medical term per se, but it is a chemical element with symbol Li and atomic number 3. In the field of medicine, lithium is most commonly referred to as a medication, specifically as "lithium carbonate" or "lithium citrate," which are used primarily to treat bipolar disorder. These medications work by stabilizing mood and reducing the severity and frequency of manic episodes.

Lithium is a naturally occurring substance, and it is an alkali metal. In its elemental form, lithium is highly reactive and flammable. However, when combined with carbonate or citrate ions to form lithium salts, it becomes more stable and safe for medical use.

It's important to note that lithium levels in the body must be closely monitored while taking this medication because too much lithium can lead to toxicity, causing symptoms such as tremors, nausea, diarrhea, and in severe cases, seizures, coma, or even death. Regular blood tests are necessary to ensure that lithium levels remain within the therapeutic range.

Pituitary neoplasms refer to abnormal growths or tumors in the pituitary gland, a small endocrine gland located at the base of the brain. These neoplasms can be benign (non-cancerous) or malignant (cancerous), with most being benign. They can vary in size and may cause various symptoms depending on their location, size, and hormonal activity.

Pituitary neoplasms can produce and secrete excess hormones, leading to a variety of endocrine disorders such as Cushing's disease (caused by excessive ACTH production), acromegaly (caused by excessive GH production), or prolactinoma (caused by excessive PRL production). They can also cause local compression symptoms due to their size, leading to headaches, vision problems, and cranial nerve palsies.

The exact causes of pituitary neoplasms are not fully understood, but genetic factors, radiation exposure, and certain inherited conditions may increase the risk of developing these tumors. Treatment options for pituitary neoplasms include surgical removal, radiation therapy, and medical management with drugs that can help control hormonal imbalances.

Collecting kidney tubules, also known as collecting ducts, are the final portion of the renal tubule in the nephron of the kidney. They collect filtrate from the distal convoluted tubules and glomeruli and are responsible for the reabsorption of water and electrolytes back into the bloodstream under the influence of antidiuretic hormone (ADH) and aldosterone. The collecting ducts then deliver the remaining filtrate to the ureter, which transports it to the bladder for storage until urination.

Polydipsia is a medical term that describes excessive thirst or an abnormally increased desire to drink fluids. It is often associated with conditions that cause increased fluid loss, such as diabetes insipidus and diabetes mellitus, as well as certain psychiatric disorders that can lead to excessive water intake. Polydipsia should not be confused with simple dehydration, where the body's overall water content is reduced due to inadequate fluid intake or excessive fluid loss. Instead, polydipsia refers to a persistent and strong drive to drink fluids, even when the body is adequately hydrated. Prolonged polydipsia can lead to complications such as hyponatremia (low sodium levels in the blood) and may indicate an underlying medical issue that requires further evaluation and treatment.

The pituitary gland is a small, endocrine gland located at the base of the brain, in the sella turcica of the sphenoid bone. It is often called the "master gland" because it controls other glands and makes the hormones that trigger many body functions. The pituitary gland measures about 0.5 cm in height and 1 cm in width, and it weighs approximately 0.5 grams.

The pituitary gland is divided into two main parts: the anterior lobe (adenohypophysis) and the posterior lobe (neurohypophysis). The anterior lobe is further divided into three zones: the pars distalis, pars intermedia, and pars tuberalis. Each part of the pituitary gland has distinct functions and produces different hormones.

The anterior pituitary gland produces and releases several important hormones, including:

* Growth hormone (GH), which regulates growth and development in children and helps maintain muscle mass and bone strength in adults.
* Thyroid-stimulating hormone (TSH), which controls the production of thyroid hormones by the thyroid gland.
* Adrenocorticotropic hormone (ACTH), which stimulates the adrenal glands to produce cortisol and other steroid hormones.
* Follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which regulate reproductive function in both males and females.
* Prolactin, which stimulates milk production in pregnant and lactating women.

The posterior pituitary gland stores and releases two hormones that are produced by the hypothalamus:

* Antidiuretic hormone (ADH), which helps regulate water balance in the body by controlling urine production.
* Oxytocin, which stimulates uterine contractions during childbirth and milk release during breastfeeding.

Overall, the pituitary gland plays a critical role in maintaining homeostasis and regulating various bodily functions, including growth, development, metabolism, and reproductive function.

I couldn't find a medical definition specifically for "Diabetes Mellitus, Experimental." However, I can provide you with information about experimental diabetes research and its relevance to understanding the disease.

Experimental diabetes models are used in biomedical research to study the pathophysiology of diabetes mellitus and to test potential therapies or treatments. These models can be broadly categorized into two types: chemically-induced and genetically modified.

1. Chemically-induced diabetes models: These involve administering chemicals, such as alloxan or streptozotocin, to animals (commonly mice or rats) to destroy their pancreatic β-cells, which produce insulin. This results in hyperglycemia and symptoms similar to those seen in type 1 diabetes in humans.
2. Genetically modified diabetes models: These involve altering the genes of animals (commonly mice) to create a diabetes phenotype. Examples include non-obese diabetic (NOD) mice, which develop an autoimmune form of diabetes similar to human type 1 diabetes, and various strains of obese mice with insulin resistance, such as ob/ob or db/db mice, which model aspects of type 2 diabetes.

These experimental models help researchers better understand the mechanisms behind diabetes development and progression, identify new therapeutic targets, and test potential treatments before moving on to human clinical trials. However, it's essential to recognize that these models may not fully replicate all aspects of human diabetes, so findings from animal studies should be interpreted with caution.

Neuroendoscopy is a minimally invasive surgical technique that involves the use of an endoscope to access and treat various conditions within the brain and spinal column. An endoscope is a long, flexible tube with a light and camera at its tip, which allows surgeons to view and operate on internal structures through small incisions or natural openings in the body.

In neuroendoscopy, the surgeon uses the endoscope to navigate through the brain's ventricular system (fluid-filled spaces) or other narrow spaces within the skull or spine to diagnose and treat conditions such as hydrocephalus, brain tumors, arachnoid cysts, and intraventricular hemorrhage.

The benefits of neuroendoscopy include reduced trauma to surrounding tissues, shorter hospital stays, faster recovery times, and improved outcomes compared to traditional open surgical approaches. However, neuroendoscopic procedures require specialized training and expertise due to the complexity of the anatomy involved.

Inappropriate Antidiuretic Hormone (ADH) Syndrome, also known as the Syndrome of Inappropriate Antidiuresis (SIAD), is a condition characterized by the excessive release or action of antidiuretic hormone (ADH) leading to an imbalance of water and electrolytes in the body.

ADH is a hormone produced by the pituitary gland that helps regulate water balance in the body by controlling the amount of urine produced by the kidneys. In normal conditions, ADH levels increase in response to dehydration or decreased blood volume, causing the kidneys to retain water and decrease urine output.

However, in Inappropriate ADH Syndrome, there is an overproduction or inappropriate release of ADH, even when the body does not need it. This can lead to a condition called hyponatremia, which is low sodium levels in the blood. Hyponatremia can cause symptoms such as headache, confusion, seizures, and in severe cases, coma or death.

Inappropriate ADH Syndrome can be caused by various factors, including certain medications, brain tumors, lung diseases, and other medical conditions that affect the production or release of ADH. It is important to diagnose and treat Inappropriate ADH Syndrome promptly to prevent serious complications from hyponatremia. Treatment typically involves addressing the underlying cause and adjusting fluid intake and electrolyte levels as needed.

Urine is a physiological excretory product that is primarily composed of water, urea, and various ions (such as sodium, potassium, chloride, and others) that are the byproducts of protein metabolism. It also contains small amounts of other substances like uric acid, creatinine, ammonia, and various organic compounds. Urine is produced by the kidneys through a process called urination or micturition, where it is filtered from the blood and then stored in the bladder until it is excreted from the body through the urethra. The color, volume, and composition of urine can provide important diagnostic information about various medical conditions.

Lithium carbonate is a medical inorganic salt that is commonly used as a medication, particularly in the treatment of bipolar disorder. It works by stabilizing mood and reducing the severity and frequency of manic episodes. Lithium carbonate is available in immediate-release and extended-release forms, and it is typically taken orally in the form of tablets or capsules.

The medical definition of lithium carbonate is: "A white, crystalline powder used as a mood-stabilizing drug, primarily in the treatment of bipolar disorder. It acts by reducing the availability of sodium and potassium ions within nerve cells, which alters the electrical activity of the brain and helps to regulate mood. Lithium carbonate is also used in the treatment of cluster headaches and to reduce aggression in patients with behavioral disorders."

It's important to note that lithium carbonate requires careful medical supervision due to its narrow therapeutic index, meaning there is a small range between an effective dose and a toxic one. Regular monitoring of blood levels is necessary to ensure safe and effective treatment.

Optic atrophy is a medical term that refers to the degeneration and shrinkage (atrophy) of the optic nerve, which transmits visual information from the eye to the brain. This condition can result in various vision abnormalities, including loss of visual acuity, color vision deficiencies, and peripheral vision loss.

Optic atrophy can occur due to a variety of causes, such as:

* Traumatic injuries to the eye or optic nerve
* Glaucoma
* Optic neuritis (inflammation of the optic nerve)
* Ischemic optic neuropathy (reduced blood flow to the optic nerve)
* Compression or swelling of the optic nerve
* Hereditary or congenital conditions affecting the optic nerve
* Toxins and certain medications that can damage the optic nerve.

The diagnosis of optic atrophy typically involves a comprehensive eye examination, including visual acuity testing, refraction assessment, slit-lamp examination, and dilated funduscopic examination to evaluate the health of the optic nerve. In some cases, additional diagnostic tests such as visual field testing, optical coherence tomography (OCT), or magnetic resonance imaging (MRI) may be necessary to confirm the diagnosis and determine the underlying cause.

There is no specific treatment for optic atrophy, but addressing the underlying cause can help prevent further damage to the optic nerve. In some cases, vision rehabilitation may be recommended to help patients adapt to their visual impairment.

Pituitary function tests are a group of diagnostic exams that evaluate the proper functioning of the pituitary gland, a small endocrine gland located at the base of the brain. The pituitary gland is responsible for producing and releasing several essential hormones that regulate various bodily functions, including growth, metabolism, stress response, reproduction, and lactation.

These tests typically involve measuring the levels of different hormones in the blood, stimulating or suppressing the pituitary gland with specific medications, and assessing the body's response to these challenges. Some common pituitary function tests include:

1. Growth hormone (GH) testing: Measures GH levels in the blood, often after a provocative test using substances like insulin, arginine, clonidine, or glucagon to stimulate GH release.
2. Thyroid-stimulating hormone (TSH) and free thyroxine (FT4) testing: Assesses the function of the thyroid gland by measuring TSH and FT4 levels in response to TRH (thyrotropin-releasing hormone) stimulation.
3. Adrenocorticotropic hormone (ACTH) and cortisol testing: Evaluates the hypothalamic-pituitary-adrenal axis by measuring ACTH and cortisol levels after a CRH (corticotropin-releasing hormone) stimulation test or an insulin tolerance test.
4. Prolactin (PRL) testing: Measures PRL levels in the blood, which can be elevated due to pituitary tumors or other conditions affecting the hypothalamus.
5. Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) testing: Assesses reproductive function by measuring FSH and LH levels, often in conjunction with estradiol or testosterone levels.
6. Gonadotropin-releasing hormone (GnRH) stimulation test: Evaluates gonadal function by measuring FSH and LH levels after GnRH administration.
7. Growth hormone (GH) testing: Measures GH levels in response to various stimuli, such as insulin-like growth factor-1 (IGF-1), glucagon, or arginine.
8. Vasopressin (ADH) testing: Assesses the posterior pituitary function by measuring ADH levels and performing a water deprivation test.

These tests can help diagnose various pituitary disorders, such as hypopituitarism, hyperpituitarism, or pituitary tumors, and guide appropriate treatment strategies.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Dehydration is a condition that occurs when your body loses more fluids than it takes in. It's normal to lose water throughout the day through activities like breathing, sweating, and urinating; however, if you don't replenish this lost fluid, your body can become dehydrated.

Mild to moderate dehydration can cause symptoms such as:
- Dry mouth
- Fatigue or weakness
- Dizziness or lightheadedness
- Headache
- Dark colored urine
- Muscle cramps

Severe dehydration can lead to more serious health problems, including heat injury, urinary and kidney problems, seizures, and even hypovolemic shock, a life-threatening condition that occurs when your blood volume is too low.

Dehydration can be caused by various factors such as illness (e.g., diarrhea, vomiting), excessive sweating, high fever, burns, alcohol consumption, and certain medications. It's essential to stay hydrated by drinking plenty of fluids, especially during hot weather, exercise, or when you're ill.

Hyponatremia is a condition characterized by abnormally low sodium levels in the blood, specifically levels less than 135 mEq/L. Sodium is an essential electrolyte that helps regulate water balance in and around your cells and plays a crucial role in nerve and muscle function. Hyponatremia can occur due to various reasons, including certain medical conditions, medications, or excessive water intake leading to dilution of sodium in the body. Symptoms may range from mild, such as nausea, confusion, and headache, to severe, like seizures, coma, or even death in extreme cases. It's essential to seek medical attention if you suspect hyponatremia, as prompt diagnosis and treatment are vital for a favorable outcome.

Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to the accumulation of urine. This occurs when the flow of urine from the kidney to the bladder is obstructed, causing urine to back up into the kidney. The obstruction can be caused by various factors such as kidney stones, tumors, or congenital abnormalities. If left untreated, hydronephrosis can lead to serious complications including kidney damage and infection. It is typically diagnosed through imaging tests such as ultrasound, CT scan, or MRI.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

Bendroflumethiazide is a diuretic medication, which means it helps the body get rid of excess salt and water by increasing urine production. It is primarily used to treat high blood pressure and edema (swelling) caused by various medical conditions.

The drug works by inhibiting the reabsorption of sodium and chloride ions in the distal convoluted tubule of the kidney, which leads to increased water excretion. This results in a decrease in blood volume and, consequently, reduced blood pressure.

Bendroflumethiazide is available under various brand names, such as Aprinox, Corrida, and Natrilix. It's important to note that this medication should only be taken under the supervision of a healthcare professional, as it can have side effects and interact with other medications.

The term "drinking" is commonly used to refer to the consumption of beverages, but in a medical context, it usually refers to the consumption of alcoholic drinks. According to the Merriam-Webster Medical Dictionary, "drinking" is defined as:

1. The act or habit of swallowing liquid (such as water, juice, or alcohol)
2. The ingestion of alcoholic beverages

It's important to note that while moderate drinking may not pose significant health risks for some individuals, excessive or binge drinking can lead to a range of negative health consequences, including addiction, liver disease, heart disease, and increased risk of injury or violence.

The endocrine system is a complex network of glands and organs that produce, store, and secrete hormones. It plays a crucial role in regulating various functions in the body, including metabolism, growth and development, tissue function, sexual function, reproduction, sleep, and mood.

Endocrine system diseases or disorders occur when there is a problem with the production or regulation of hormones. This can result from:

1. Overproduction or underproduction of hormones by the endocrine glands.
2. Impaired response of target cells to hormones.
3. Disruption in the feedback mechanisms that regulate hormone production.

Examples of endocrine system diseases include:

1. Diabetes Mellitus - a group of metabolic disorders characterized by high blood sugar levels due to insulin deficiency or resistance.
2. Hypothyroidism - underactive thyroid gland leading to slow metabolism, weight gain, fatigue, and depression.
3. Hyperthyroidism - overactive thyroid gland causing rapid heartbeat, anxiety, weight loss, and heat intolerance.
4. Cushing's Syndrome - excess cortisol production resulting in obesity, high blood pressure, and weak muscles.
5. Addison's Disease - insufficient adrenal hormone production leading to weakness, fatigue, and low blood pressure.
6. Acromegaly - overproduction of growth hormone after puberty causing enlargement of bones, organs, and soft tissues.
7. Gigantism - similar to acromegaly but occurs before puberty resulting in excessive height and body size.
8. Hypopituitarism - underactive pituitary gland leading to deficiencies in various hormones.
9. Hyperparathyroidism - overactivity of the parathyroid glands causing calcium imbalances and kidney stones.
10. Precocious Puberty - early onset of puberty due to premature activation of the pituitary gland.

Treatment for endocrine system diseases varies depending on the specific disorder and may involve medication, surgery, lifestyle changes, or a combination of these approaches.

Renal aminoacidurias are a group of inherited kidney disorders characterized by the abnormal excretion of amino acids in the urine (aminoaciduria). This condition results from defects in the renal tubular transport systems that are responsible for the reabsorption of amino acids from the filtrate in the kidneys.

There are several types of renal aminoacidurias, each associated with a specific genetic mutation affecting different transporter proteins in the proximal renal tubules. The most common type is cystinuria, which is caused by a defect in the transport system for four amino acids: cystine, ornithine, lysine, and arginine. Other types of renal aminoacidurias include Hartnup disorder, Lowe syndrome, and Dent disease, among others.

The clinical manifestations of renal aminoacidurias vary depending on the specific type and severity of the disorder. Some individuals may be asymptomatic or have only mild symptoms, while others may experience severe complications such as kidney stones, urinary tract infections, neurological symptoms, or growth retardation.

Treatment for renal aminoacidurias typically involves dietary modifications, increased fluid intake, and medications to reduce the risk of kidney stone formation and other complications. In some cases, surgery may be necessary to remove large kidney stones.

Aquaporin 3 (AQP3) is a type of aquaglyceroporin, which is a subclass of aquaporins - water channel proteins that facilitate the transport of water and small solutes across biological membranes. AQP3 is primarily expressed in the epithelial cells of various tissues, including the skin, kidneys, and gastrointestinal tract.

In the skin, AQP3 plays a crucial role in maintaining skin hydration by facilitating water transport across the cell membrane. It also transports small neutral solutes like glycerol and urea, which contribute to skin moisturization and elasticity. In addition, AQP3 has been implicated in several physiological processes, such as wound healing, epidermal proliferation, and cutaneous sensory perception.

In the kidneys, AQP3 is involved in water reabsorption in the collecting ducts, helping to regulate body fluid homeostasis. In the gastrointestinal tract, it facilitates water absorption and secretion, contributing to maintaining proper hydration and electrolyte balance. Dysregulation of AQP3 has been associated with various pathological conditions, such as skin disorders, kidney diseases, and cancer.

Gestational diabetes is a type of diabetes that occurs during pregnancy. It is characterized by an increase in blood sugar levels that begins or is first recognized during pregnancy. The condition usually develops around the 24th week of gestation and is caused by the body's inability to produce enough insulin to meet the increased demands of pregnancy.

Gestational diabetes typically resolves after delivery, but women who have had gestational diabetes are at an increased risk of developing type 2 diabetes later in life. It is important for women with gestational diabetes to manage their blood sugar levels during pregnancy to reduce the risk of complications for both the mother and the baby.

Management of gestational diabetes may include lifestyle modifications such as dietary changes and exercise, as well as monitoring blood sugar levels and potentially using insulin or other medications to control blood sugar levels. Regular prenatal care is essential for women with gestational diabetes to ensure that their blood sugar levels are properly managed and to monitor the growth and development of the fetus.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Renal tubular acidosis (RTA) is a medical condition that occurs when the kidneys are unable to properly excrete acid into the urine, leading to an accumulation of acid in the bloodstream. This results in a state of metabolic acidosis.

There are several types of RTA, but renal tubular acidosis type 1 (also known as distal RTA) is characterized by a defect in the ability of the distal tubules to acidify the urine, leading to an inability to lower the pH of the urine below 5.5, even in the face of metabolic acidosis. This results in a persistently alkaline urine, which can lead to calcium phosphate stones and bone demineralization.

Type 1 RTA is often caused by inherited genetic defects, but it can also be acquired due to various kidney diseases, drugs, or autoimmune disorders. Symptoms of type 1 RTA may include fatigue, weakness, muscle cramps, decreased appetite, and vomiting. Treatment typically involves alkali therapy to correct the acidosis and prevent complications.

Blood glucose, also known as blood sugar, is the concentration of glucose in the blood. Glucose is a simple sugar that serves as the main source of energy for the body's cells. It is carried to each cell through the bloodstream and is absorbed into the cells with the help of insulin, a hormone produced by the pancreas.

The normal range for blood glucose levels in humans is typically between 70 and 130 milligrams per deciliter (mg/dL) when fasting, and less than 180 mg/dL after meals. Levels that are consistently higher than this may indicate diabetes or other metabolic disorders.

Blood glucose levels can be measured through a variety of methods, including fingerstick blood tests, continuous glucose monitoring systems, and laboratory tests. Regular monitoring of blood glucose levels is important for people with diabetes to help manage their condition and prevent complications.

Adrenal insufficiency is a condition in which the adrenal glands do not produce adequate amounts of certain hormones, primarily cortisol and aldosterone. Cortisol helps regulate metabolism, respond to stress, and suppress inflammation, while aldosterone helps regulate sodium and potassium levels in the body to maintain blood pressure.

Primary adrenal insufficiency, also known as Addison's disease, occurs when there is damage to the adrenal glands themselves, often due to autoimmune disorders, infections, or certain medications. Secondary adrenal insufficiency occurs when the pituitary gland fails to produce enough adrenocorticotropic hormone (ACTH), which stimulates the adrenal glands to produce cortisol.

Symptoms of adrenal insufficiency may include fatigue, weakness, weight loss, decreased appetite, nausea, vomiting, diarrhea, abdominal pain, low blood pressure, dizziness, and darkening of the skin. Treatment typically involves replacing the missing hormones with medications taken orally or by injection.

Urination, also known as micturition, is the physiological process of excreting urine from the urinary bladder through the urethra. It is a complex process that involves several systems in the body, including the urinary system, nervous system, and muscular system.

In medical terms, urination is defined as the voluntary or involuntary discharge of urine from the urethra, which is the final pathway for the elimination of waste products from the body. The process is regulated by a complex interplay between the detrusor muscle of the bladder, the internal and external sphincters of the urethra, and the nervous system.

During urination, the detrusor muscle contracts, causing the bladder to empty, while the sphincters relax to allow the urine to flow through the urethra and out of the body. The nervous system plays a crucial role in coordinating these actions, with sensory receptors in the bladder sending signals to the brain when it is time to urinate.

Urination is essential for maintaining the balance of fluids and electrolytes in the body, as well as eliminating waste products such as urea, creatinine, and other metabolic byproducts. Abnormalities in urination can indicate underlying medical conditions, such as urinary tract infections, bladder dysfunction, or neurological disorders.

Halofenate is not typically considered a medication with a primary use in modern medical practice. However, historically it has been used as a treatment for gout and hyperuricemia (high levels of uric acid in the blood). It is a compound with both uricosuric and anti-inflammatory properties.

The uricosuric action of halofenate helps to lower serum uric acid levels by increasing its excretion in the urine, while its anti-inflammatory effects may help alleviate symptoms associated with gout attacks. It is important to note that due to its limited use and potential side effects, other medications are often preferred for managing gout and hyperuricemia.

Please consult a healthcare professional or pharmacist for more information about specific medications and treatment options.

Sodium chloride symporter inhibitors are a class of pharmaceutical agents that block the function of the sodium chloride symporter (NCC), which is a protein found in the kidney's distal convoluted tubule. The NCC is responsible for reabsorbing sodium and chloride ions from the filtrate back into the bloodstream, helping to regulate electrolyte balance and blood pressure.

Sodium chloride symporter inhibitors work by selectively binding to and blocking the NCC, preventing it from transporting sodium and chloride ions across the cell membrane. This leads to increased excretion of sodium and chloride in the urine, which can help lower blood pressure in patients with hypertension.

Examples of sodium chloride symporter inhibitors include thiazide diuretics such as hydrochlorothiazide and chlorthalidone, which have been used for many years to treat hypertension and edema associated with heart failure and liver cirrhosis. These medications work by reducing the amount of sodium and fluid in the body, which helps lower blood pressure and reduce swelling.

It's worth noting that while sodium chloride symporter inhibitors can be effective at treating hypertension, they can also cause side effects such as electrolyte imbalances, dehydration, and increased urination. As with any medication, it's important to use them under the guidance of a healthcare provider and to follow dosing instructions carefully.

Osmoregulation is the physiological process by which an organism maintains the balance of osmotic pressure, or the concentration of solutes, in its body fluids. This is achieved through various homeostatic mechanisms that involve the regulation of water and electrolyte intake and excretion. In humans, for example, the kidneys play a crucial role in maintaining osmoregulation by filtering the blood, reabsorbing necessary solutes and water, and excreting excess solutes and waste products as urine. Other organisms, such as marine fish, may use specialized organs like the gills to actively regulate their salt and water balance in response to changes in their environment.

Medical Definition of Water Intoxication:

Water intoxication, also known as hyponatremia, is a condition that occurs when an individual consumes water in such large quantities that the body's electrolyte balance is disrupted. This results in an abnormally low sodium level in the blood (hyponatremia), which can cause symptoms ranging from mild to severe, including nausea, headache, confusion, seizures, coma, and even death in extreme cases. It's important to note that water intoxication is rare and typically only occurs in situations where large amounts of water are consumed in a short period of time, such as during endurance sports or when someone is trying to intentionally harm themselves.

Glycosylated Hemoglobin A, also known as Hemoglobin A1c or HbA1c, is a form of hemoglobin that is bound to glucose. It is formed in a non-enzymatic glycation reaction with glucose in the blood. The amount of this hemoglobin present in the blood is proportional to the average plasma glucose concentration over the previous 8-12 weeks, making it a useful indicator for monitoring long-term blood glucose control in people with diabetes mellitus.

In other words, HbA1c reflects the integrated effects of glucose regulation over time and is an important clinical marker for assessing glycemic control and risk of diabetic complications. The normal range for HbA1c in individuals without diabetes is typically less than 5.7%, while a value greater than 6.5% is indicative of diabetes.

Lithium compounds refer to chemical substances that contain the element lithium (Li) combined with one or more other elements. Lithium is an alkali metal with the atomic number 3 and is highly reactive, so it is typically found in nature combined with other elements to form stable compounds.

Lithium compounds have a variety of uses, including in the production of ceramics, glass, and lubricants. However, they are perhaps best known for their use in psychiatric medicine, particularly in the treatment of bipolar disorder. Lithium carbonate (Li2CO3) is the most commonly prescribed lithium compound for this purpose.

Lithium compounds work by affecting the levels of certain neurotransmitters in the brain, including serotonin and dopamine. They can help to reduce the severity and frequency of manic episodes in people with bipolar disorder, as well as potentially having a mood-stabilizing effect. It is important to note that lithium compounds must be used under the close supervision of a healthcare provider, as they can have serious side effects if not properly monitored.

Hypogonadism is a medical condition characterized by the inability of the gonads (testes in males and ovaries in females) to produce sufficient amounts of sex hormones, such as testosterone and estrogen. This can lead to various symptoms including decreased libido, erectile dysfunction in men, irregular menstrual periods in women, and reduced fertility in both sexes. Hypogonadism may be caused by genetic factors, aging, injury to the gonads, or certain medical conditions such as pituitary disorders. It can be treated with hormone replacement therapy.

Jane JA Jr; Vance ML; Laws ER (2006). "Neurogenic diabetes insipidus". Pituitary. 9 (4): 327-9. doi:10.1007/s11102-006-0414-7. ... Finally, 10-25% develop diabetes insipidus, the inability to retain fluid in the kidneys due to a lack of the pituitary ... Oxford Textbook of Endocrinology and Diabetes. Oxford: Oxford University Press. pp. 161-2. ISBN 978-0-19-263045-2. van Aken MO ...
The several forms of diabetes insipidus are: Central (or Neurogenic) DI has many possible causes. According to the literature, ... "Diabetes Insipidus vs. Diabetes Mellitus". Bichet DG (April 2006). "Nephrogenic Diabetes Insipidus". Advances in Chronic Kidney ... Hereditary forms of diabetes insipidus account for less than 10% of the cases of diabetes insipidus seen in clinical practice. ... to avoid confusion with diabetes mellitus. "Diabetes Insipidus". National Institute of Diabetes and Digestive and Kidney ...
... , also called neurogenic diabetes insipidus, is a type of diabetes insipidus due to a lack of ... "Familial Neurogenic Diabetes Insipidus: a disease caused by a traffic jam?". The Diabetes Insipidus Foundation. 2006. {{cite ... Neurogenic diabetes insipidus can be a failure of production at the hypothalamus, or a failure of release at the pituitary. The ... In at least 25% of cases (the most commonly occurring classification), neurogenic diabetes insipidus is of unknown cause, ...
Neurogenic diabetes insipidus may occur due to low levels of ADH production from the hypothalamus. Insufficient levels of ADH ... Hypopituitarism, neurogenic diabetes insipidus, tertiary hypothyroidism, and developmental disorders are examples of ... Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by ...
... neurogenic diabetes insipidus) or the kidneys' response to antidiuretic hormone (nephrogenic diabetes insipidus), diabetes ... Nephrogenic diabetes insipidus, also known as renal diabetes insipidus, is a form of diabetes insipidus primarily due to ... then the cause of the diabetes insipidus is neurogenic diabetes insipidus; if no response occurs to desmopressin, then the ... Differential diagnosis includes nephrogenic diabetes insipidus, neurogenic/central diabetes insipidus and psychogenic ...
His other works include research into aphasia and apraxia, the neurogenic origin of diabetes insipidus, the physiology of the ... dealt with the neurogenic origin of diabetes insipidus. Bremer, together with Bailey, showed that a minimal lesion of the ... Bailey, P; Bremer F. (1921). "Experimental diabetes insipidus". Arch Intern Med. 28 (6): 773-803. doi:10.1001/archinte. ... hypothalamus can induce experimental diabetes insipidus. These lesions were also shown to induce sleepiness and adiposity. In ...
... diabetes insipidus, neurogenic MeSH C19.700.159.875 - wolfram syndrome MeSH C19.700.355.179 - acromegaly MeSH C19.700.355.528 ... diabetes mellitus, lipoatrophic MeSH C19.344.078.265 - adrenal cortex neoplasms MeSH C19.344.078.265.500 - adrenocortical ...
... diabetes insipidus, nephrogenic MeSH C12.777.419.135.750 - diabetes insipidus, neurogenic MeSH C12.777.419.135.875 - wolfram ... neurogenic MeSH C12.777.103.495 - cystitis MeSH C12.777.103.495.500 - cystitis, interstitial MeSH C12.777.103.920 - vesico- ...
... central diabetes insipidus and nephrogenic diabetes insipidus. Polyuria generally causes urinary urgency and frequency, but ... Neurogenic disorders like multiple sclerosis, spina bifida, Parkinson's disease, strokes and spinal cord injury can all ... This can lead to neurogenic bladder dysfunction Overactive bladder syndrome. However, the etiology behind this is usually ... uncontrolled diabetes mellitus, primary polydipsia (excessive fluid drinking), ...
"Central Diabetes Insipidus". MSD. Merck & Co. Inc. Boron WR, Boulpaep EL (2016-05-05). Medical Physiology (Third ed.). ... neurogenic - i.e. due to alcohol intoxication or tumour) or decreased renal sensitivity to AVP (nephrogenic, i.e. by mutation ... Vasopressin is used to treat diabetes insipidus related to low levels of antidiuretic hormone. It is available as Pressyn. ... leads to diabetes insipidus, a condition featuring hypernatremia (increased blood sodium concentration), polyuria (excess urine ...
... tumor Nephrocalcinosis Nephrogenic diabetes insipidus Nephrolithiasis type 2 Nephronophthisis familial adult spastic q- ... of Riccardi Neurofibromatosis-Noonan syndrome Neurofibrosarcoma Neurogenic hypertension Neuroleptic malignant syndrome Neuroma ... type 5 Neonatal diabetes mellitus Neonatal diabetes mellitus, permanent (PNDM) Neonatal diabetes mellitus, transient (TNDM) ... Non functioning pancreatic endocrine tumor Nonallergic atopic dermatitis Non-Hodgkin lymphoma Noninsulin-dependent diabetes ...
Other causes include burns, as well as excess urine loss due to diabetic ketoacidosis and diabetes insipidus. Signs and ... High spinal injuries may cause neurogenic shock, which is commonly classified as a subset of distributive shock. The classic ... Low volume, anaphylactic, and neurogenic shock are readily treatable and respond well to medical therapy. Septic shock, ... neurogenic shock). Septic shock is the most common cause of distributive shock. It is caused by an overwhelming systemic ...
... diabetes mellitus (types 1 and 2), and diabetes insipidus Oliguria, low urine output, usually due to a problem with the upper ... This type of bladder is sometimes called the spastic neurogenic bladder. The reflex hyperactivity is made worse, and may be ... Neurogenic Bladder at eMedicine, describes the neurophysiology of urination "Urination" at HowStuffWorks.com (Pages containing ... American Urological Association (2014). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU ...
The common causes of global polyuria are primary thirst disorders such as diabetes mellitus and diabetes insipidus (DI). ... also known as prostate enlargement neurogenic bladder dysfunction learned voiding dysfunction anxiety disorders urinary tract ... Central diabetes insipidus is caused by low levels of Vasopressin (also called antidiuretic hormone (ADH), arginine vasopressin ... Rivkees, SA; Dunbar, N; Wilson, TA (2007). "The management of central diabetes insipidus in infancy: Desmopressin, low renal ...
Diabetes insipidus, which causes high frequency and volume, though not necessarily urgency. There is some controversy about the ... American Urological Association (2014). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU ... Poorly controlled diabetes, poor functional mobility, and chronic pelvic pain may worsen the symptoms. People often have the ... non-neurogenic) in adults: AUA/SUFU guideline amendment". The Journal of Urology. 193 (5): 1572-80. doi:10.1016/j.juro.2015.01. ...
Development of diabetes insipidus or an electrolyte abnormality acutely after injury indicate need for endocrinologic work up. ... Traumatic brain injury may cause a range of serious coincidental complications that include cardiac arrhythmias and neurogenic ... ISBN 978-1-84882-069-2. O'Leary R, McKinlay J (2011). "Neurogenic pulmonary oedema". Continuing Education in Anaesthesia, ...
DHCR24 Diabetes insipidus, nephrogenic; 125800; AQP2 Diabetes insipidus, nephrogenic; 304800; AVPR2 Diabetes insipidus, ... neurogenic, Kaeser type; 181400; DES Schimke immunoosseous dysplasia; 242900; SMARCAL1 Schindler disease, type I; 609241; NAGA ... KCNJ11 Diabetes mellitus, type 1; 125852; INS Diabetes mellitus, type 2; 125853; PAX4 Diabetes mellitus type II; 125853; AKT2 ... GCK Diabetes mellitus, insulin-dependent, 2; 125852; INS Diabetes mellitus, insulin-dependent, 20; 612520; HNF1A Diabetes ...
Jane JA Jr; Vance ML; Laws ER (2006). "Neurogenic diabetes insipidus". Pituitary. 9 (4): 327-9. doi:10.1007/s11102-006-0414-7. ... Finally, 10-25% develop diabetes insipidus, the inability to retain fluid in the kidneys due to a lack of the pituitary ... Oxford Textbook of Endocrinology and Diabetes. Oxford: Oxford University Press. pp. 161-2. ISBN 978-0-19-263045-2. van Aken MO ...
Central diabetes insipidus is a rare condition that involves extreme thirst and excessive urination. ... Central diabetes insipidus is a rare condition that involves extreme thirst and excessive urination. ... Contact your provider if you develop symptoms of central diabetes insipidus.. If you have central diabetes insipidus, contact ... Diabetes insipidus (DI) is an uncommon condition in which the kidneys are unable to prevent the excretion of water. DI is a ...
... neurogenic, pituitary, or neurohypophyseal) DI, characterized by decreased secretion of antidiuretic hormone (ADH; also ... Diabetes insipidus (DI) is defined as the passage of large volumes (>3 L/24 hr) of dilute urine (< 300 mOsm/kg). It has the ... encoded search term (Diabetes Insipidus) and Diabetes Insipidus What to Read Next on Medscape ... Mutations in WFS1 lead to Wolfram syndrome, which is also known by the acronym DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, ...
... neurogenic, pituitary, or neurohypophyseal) DI, characterized by decreased secretion of antidiuretic hormone (ADH; also ... Diabetes insipidus (DI) is defined as the passage of large volumes (>3 L/24 hr) of dilute urine (< 300 mOsm/kg). It has the ... encoded search term (Diabetes Insipidus) and Diabetes Insipidus What to Read Next on Medscape ... Mutations in WFS1 lead to Wolfram syndrome, which is also known by the acronym DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, ...
Neurogenic Diabetes Insipidus. Nonfunctioning Pituitary Adenoma. Osteitis Fibrosa Cystica. Pancreas Neuroendocrine Tumors ... Diabetes mellitus: considerations for dentistry. Journal of the American Dental Association (1939), 139 Suppl , 8S-18S ... American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care ... American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 2004-11-03) - (Recertification ...
... rare and the usual localisations are the retro-orbital space and hypothalamic involvement with neurogenic diabetes insipidus. ... and the hypophyso-hypothalamic area with diabetes insipidus (17 patients).2 The most frequent systemic histiocytosis is ...
When associated with a net water loss, diabetes insipidus (either neurogenic or nephrogenic) can be a cause. Osmolality tests ( ... Diabetes insipidus is a possible cause of hypernatraemia. 92%. Question 4 comments. A patient should be referred to secondary ... therapy is nephrogenic diabetes insipidus (causing a net water loss). Medicines such as loop diuretics, mannitol, urea, ... excl diabetes)Feature lettersGastroenterologyGeneticsGenitourinary system (male)GuidelinesGynaecology and urinary tract ...
... leading to neurogenic diabetes insipidus and a marked decrease in the levels of thyroid hormone, resulting in the inhibition of ... Aspiration pneumonitis, pulmonary contusions, neurogenic pulmonary edema and pneumonia are common complicating factors in ...
DIABETES INSIPIDA NEUROGENICA. DIABETES INSIPIDUS, NEUROGENIC. DIABETES INSÍPIDO NEUROGÊNICO. DICLOFENACO SODICO. DICLOFENAC ...
DIABETES INSIPIDA NEUROGENICA. DIABETES INSIPIDUS, NEUROGENIC. DIABETES INSÍPIDO NEUROGÊNICO. DICLOFENACO SODICO. DICLOFENAC ...
DIABETES INSIPIDA NEUROGENICA. DIABETES INSIPIDUS, NEUROGENIC. DIABETES INSÍPIDO NEUROGÊNICO. DICLOFENACO SODICO. DICLOFENAC ...
DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DIABETES INSÍPIDO NEUROGÊNICO DIAGONAL BAND OF BROCA BANDA ...
DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DIABETES INSÍPIDO NEUROGÊNICO DIAGONAL BAND OF BROCA BANDA ...
DIABETES INSÍPIDO NEUROGÊNICO DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DICLOFENACO SÓDICO DICLOFENAC SODIUM ...
DIABETES INSIPIDA NEUROGENICA. DIABETES INSIPIDUS, NEUROGENIC. DIABETES INSÍPIDO NEUROGÊNICO. DICLOFENACO SODICO. DICLOFENAC ...
DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DIABETES INSÍPIDO NEUROGÊNICO DIAGONAL BAND OF BROCA BANDA ...
DIABETES INSÍPIDO NEUROGÊNICO DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DICLOFENACO SÓDICO DICLOFENAC SODIUM ...
DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DIABETES INSÍPIDO NEUROGÊNICO DIAGONAL BAND OF BROCA BANDA ...
DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DIABETES INSÍPIDO NEUROGÊNICO DIAGONAL BAND OF BROCA BANDA ...
DIABETES INSÍPIDO NEUROGÊNICO DIABETES INSIPIDUS, NEUROGENIC DIABETES INSIPIDA NEUROGENICA DICLOFENACO SÓDICO DICLOFENAC SODIUM ...
Manifestation of central diabetes insipidus in a patient with thyroid storm. Nakamichi, A., Ocho, K., Oka, K., Yasuda, M., ...
neurogenic (central) diabetes insipidus *neurodegeneration characterized by psychomotor deterioration and ataxia * obstructive ... Diabetes insipidus. This is the most common CNS manifestation of LCH . Patients with diabetes insipidus in LCH demonstrate a ... with new onset diabetes insipidus. Sagittal T1 MRI without contrast (above left) of the brain shows absence of the posterior ... Langerhans cell histiocytosis in a 6-year-old girl with headaches and diabetes insipidus. Coronal T1WI shows a lesion involving ...
Lack of ADH → Diabetes insipidus.. 2 types of DI:. a. Neurogenic (central or cranial) ... Diabetes Insipidus. Symptoms:. Polyurea  20 L/day (N  1.5 L/d),. Polydypsia,.  specific gravity of urine (diluted urine),. ... ADH will be given in neurogenic Diabetes insipidus. *No ADH will be given in nephrogenic Diabetes insipidus ...
Unlabeled use(s): Management of neurogenic diabetes insipidus; treatment of certain psychiatric disorders; management of ...
The cause of neurogenic diabetes insipidus (DI) is related to an organic lesion of the ... Do elderly patients with Type 2 diabetes show improvement with episodes of hypoglycemia, FBS and HgBA1C with Degludec? ... What causes the microvascular complications of clients with diabetes mellitus?. The capillaries contain plaques of lipids that ...
AdultAgedBrain AbscessDiabetes Insipidus, NeurogenicFemaleFeverFollow-Up StudiesHeadacheHumansHypopituitarismMaleMiddle Aged ...
Diabetes insipidus(DI) is characterised by extreme thirst and the passing of vast amounts of urine. It is caused by ... Different types of diabetes insipidus. The cases of diabetes insipidus are grouped by cause such as:. *Neurogenic - Vasopressin ... Diabetes Insipidus : Symptoms, Types , Complications, Diagnosis, Treatment. Symptoms of diabetes insipidus (DI) the release of ... Diabetes Insipidus or Water Diabetes -Video Guide. Too much water is lost in the urine. The kidneys excrete urine. These organs ...
Unlabeled uses: Neurogenic diabetes insipidus (200 mg bid-tid); certain psychiatric disorders, including bipolar disorders, ... This is especially common in people who have diabetes. To resolve the issue, you should eat something when you feel dizzy and ...
... neurogenic, pituitary, or neurohypophyseal) DI, characterized by decreased secretion of antidiuretic hormone (ADH; also ... Diabetes insipidus (DI) is defined as the passage of large volumes (>3 L/24 hr) of dilute urine (< 300 mOsm/kg). It has the ... encoded search term (Diabetes Insipidus) and Diabetes Insipidus What to Read Next on Medscape ... Mutations in WFS1 lead to Wolfram syndrome, which is also known by the acronym DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, ...
  • When associated with a net water loss, diabetes insipidus (either neurogenic or nephrogenic) can be a cause. (bpac.org.nz)
  • Nephrogenic diabetes insipidus among adults can be due to hypercalcemia and treatment with lithium. (ada-diabetes-management.com)
  • This disease is further categorized as Nephrogenic Diabetes Insipidus and Neurogenic Diabetes Insipidus. (timeslifestyle.net)
  • This document was uploaded by user and they man disease (1), and nephrogenic diabetes insipidus (NDI) is an example: It is the nephrogenic failure to concentrate urine in response to the antidiuretic May 6, 2019 Diabetes insipidus (DI) is an uncommon condition in which the kidneys are unable to prevent the excretion of water. (web.app)
  • Diabetes Insipidus can result from reduced posterior pituitary secretion of ADH, referred to as Central DI, or due to reduced renal response to the action of appropriately-secreted ADH, referred to as Nephrogenic DI.These basic etiological categories can be easily clinically distinguished by injecting recombinant ADH which will correct central DI but not nephrogenic DI. (web.app)
  • 2. Nephrogenic diabetes insipidus: This type of diabetes insipidus is also common but lower than the first type called Nephrogenic diabetes insipidus. (diabetestalk.net)
  • Nephrogenic diabetes insipidus, also known as Acquired Nephrogenic Diabetes Insipidus (ANDI) and Congenital Diabetes Insipidus is a form of diabetes insipidus which is due to the pathology of the kidney. (targetwoman.com)
  • Nephrogenic diabetes insipidus is caused by improper response of the kidneys to ADH and this leads to disability of the kidney to concentrate the urine by removing the water. (targetwoman.com)
  • Conditions such as cystitis, constipation, urethral obstruction, and neurogenic bladder reduce functional bladder capacity which can cause enuresis [ 3 , 4 ]. (chikd.org)
  • Diabetes mellitus and diabetes insipidus may lead to polyuria [ 2 ]. (chikd.org)
  • The only symptoms in primary central diabetes insipidus are polydipsia and polyuria. (diabetestalk.net)
  • The classic symptoms of diabetes are polyuria (frequent urination), polydipsia (increased thirst), polyphagia (increased hunger), and weight loss . (thediabeticpharmacist.com)
  • Diabetes mellitus, polyuria can be the first sign of undiagnosed or uncontrolled diabetes mellitus. (niroginepal.com)
  • Diabetes insipidus (DI) is an uncommon condition in which the kidneys are unable to prevent the excretion of water. (medlineplus.gov)
  • Diabetes insipidus can either be due to the kidneys not being sensitive to vasopressin or insufficient vasopressin is produced by the hypothalamus. (ada-diabetes-management.com)
  • This is a comparatively rare type of diabetes insipidus which is due to a genetic disorder which affects the tiny structures inside the kidneys, known as tubules, which absorb water. (ada-diabetes-management.com)
  • If left untreated Diabetes Insipidus can permanently damage the kidneys. (timeslifestyle.net)
  • Diabetes insipidus, a disease in which kidneys are not able to regulate water balance due to decreased production or action of antidiuretic hormones (ADH). (niroginepal.com)
  • In rare cases, enuresis is an early symptom of endocrine disorders such as diabetes or thyroid disorders. (chikd.org)
  • It is the Neurological form called Central Diabetes Insipidus, which involves a deficiency of arginine vasopressin. (diabetestalk.net)
  • The condition of Diabetes Insipidus is not , and often the proper diagnosis of it will involve the exclusion of other conditions with similar symptoms. (timeslifestyle.net)
  • Diabetes Insipidus Diagnosis Diabetes insipidus is a circumstance characterized by unnecessary extreme thirst and emission of huge amounts of severely reduce of urine along with the decrease of fluid intake having no outcome on the attentiveness of the urine. (diabetestalk.net)
  • DI is a different disease than diabetes , though both share common symptoms of excessive urination and thirst. (medlineplus.gov)
  • Contact your provider if you develop symptoms of central diabetes insipidus. (medlineplus.gov)
  • Symptoms of diabetes insipidus (DI) the release of a large quantity of urine and an unquenchable thirst. (ada-diabetes-management.com)
  • Weve composed before about the signs and symptoms of diabetes. (diabetesprohelp.com)
  • While there are a great deal of sources about what symptoms diabetes causes, as well as some excellent info about why theyre bad for you, what you do not frequently get are the whys. (diabetesprohelp.com)
  • That, in turn, can help with acceptance and understanding of how to much better treat the symptoms, which in turn can help you remain on an excellent diabetes management routine. (diabetesprohelp.com)
  • Two of the most common symptoms of diabetes are increased thirst and increased urine production. (diabetesprohelp.com)
  • The most common symptoms of diabetes are often referred to as The Three P's of diabetes. (diabetesprohelp.com)
  • Something to bear in mind is that the causes of these symptoms are not the same as type 1 and type 2 diabetes. (timeslifestyle.net)
  • In secondary central diabetes insipidus, symptoms and signs of the associated lesions are also present. (diabetestalk.net)
  • Diabetes Insipidus Signs and Symptoms There are some signs and symptoms of diabetes insipidus. (diabetestalk.net)
  • But the most common signs and symptoms of diabetes insipidus are two in below: 1. (diabetestalk.net)
  • Overview of the most significant symptoms of diabetes. (thediabeticpharmacist.com)
  • The diabetes in this condition gives the meaning to go through which describes the amount of urine released. (ada-diabetes-management.com)
  • The word insipidus tells us the urine has no taste while the word mellitus implies the urine is sweet as a result of the sugar in it. (ada-diabetes-management.com)
  • The release of big quantities of urine and excessive thirst characterized Diabetes insipidus. (ada-diabetes-management.com)
  • Abnormal urination and thirst, unexplained hunger, fatigue, unexplained irritability, including the presence of ketones in the urine, and sometimes even blurred vision can be an early sign of diabetes. (diabetesprohelp.com)
  • Those who suffer from Diabetes Insipidus tend to produce alarming amounts of urine which are the direct result of constant urination and thirst. (timeslifestyle.net)
  • This results in a person suffering from Diabetes Insipidus losing large amounts of water through the urine, prompting the patient to drink large amounts of water. (timeslifestyle.net)
  • Diabetes insipidus, characterized by excretion of copious volumes of dilute urine, can be [PDF] Askep Diabetes Insipidus - Free Download PDF Apr 13, 2020 · Download Askep Diabetes Insipidus. (web.app)
  • Central diabetes insipidus is a form of DI that occurs when the body has a lower than normal amount of antidiuretic hormone (ADH). (medlineplus.gov)
  • Diabetes insipidus and syndrome of inappropriate antidiuretic hormone. (medlineplus.gov)
  • Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst. (reference.md)
  • Other terms for central DI are neurogenic, pituitary, and neurohypophyseal DI. (medscape.com)
  • The sever-ity and mechanism of neurogenic bowel dysfunction upper motor neuron activity and osteoclastic activity may be required in an average american pediatric practice have used alcohol within the right side of the external structures of the, therefore. (albionfoundation.org)
  • Diabetes mellitus type 2 (formerly noninsulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes ) is a metabolic disorder that is characterized by high blood glucose in the context of insulin resistance and relative insulin deficiency. (thediabeticpharmacist.com)
  • [ 2 ] This is in contrast to diabetes mellitus type 1 , in which there is an absolute insulin deficiency due to destruction of islet cells in the pancreas . (thediabeticpharmacist.com)
  • Type 2 diabetes makes up about 90% of cases of diabetes with the other 10% due primarily to diabetes mellitus type 1 and gestational diabetes . (thediabeticpharmacist.com)
  • Central diabetes insipidus is a rare condition that involves extreme thirst and excessive urination. (medlineplus.gov)
  • If you have central diabetes insipidus, contact your provider if frequent urination or extreme thirst returns. (medlineplus.gov)
  • Diabetes Insipidus is a chronic disease in which the body loses a lot of its fluids through constant urination leading to concerning risks of dehydration as several other diseases and complications related to this disease. (timeslifestyle.net)
  • Diabetes Insipidus is a disease that affects our body ability to regulate and control water balance, resulting in constant urination. (timeslifestyle.net)
  • Intracranial manifestations are rare and the usual localisations are the retro-orbital space and hypothalamic involvement with neurogenic diabetes insipidus. (bmj.com)
  • If youre constantly thirsty, the first step should be to go to a doctor to check if your thirst is a result of diabetes. (diabetesprohelp.com)
  • A secondary symptom involving Diabetes Insipidus is dehydration due to the increasing loss of water, this is particularly worrisome in young children who can't sometimes communicate their thirst. (timeslifestyle.net)
  • The pathology of central diabetes insipidus thus always involves the supraoptic and paraventricular nuclei of the hypothalamus or a major portion of the pituitary stalk. (diabetestalk.net)
  • Algorithm for the management of neurogenic incontinence. (medscape.com)
  • Neurogenic - Vasopressin is insufficiently produced by the brain. (ada-diabetes-management.com)
  • The cause determines the treatment of diabetes insipidus.Vasopressin is replaced if DI is caused by insufficient vasopressin. (ada-diabetes-management.com)
  • Transient diabetes insipidus in pregnancy Sep 23, 2015 · Gestational diabetes insipidus (DI) is a rare complication of pregnancy, usually developing in the third trimester and remitting spontaneously 4-6 weeks post-partum.It is mainly caused by excessive vasopressinase activity, an enzyme expressed by placental trophoblasts which metabolises arginine vasopressin (AVP). (web.app)
  • The frequent urge to go is one of the first and most common signs of diabetes. (decadethirty.com)
  • with new onset diabetes insipidus. (pacs.de)
  • Onset of central diabetes insipidus may be insidious or abrupt, occurring at any age. (diabetestalk.net)
  • Unless treated, a person with diabetes insipidus can suffer from dehydration and, as the salts, especially sodium, in the bloodstream become concentrated, goes into a coma because of the salt concentration. (ada-diabetes-management.com)
  • Diabetes Insipidus can lead to dangerous levels of dehydration if the patient does not increases the levels of liquids intake. (timeslifestyle.net)
  • Type 2 diabetes is typically a chronic disease associated with a ten-year-shorter life expectancy. (thediabeticpharmacist.com)
  • This is in contrast to the central and Neurogenic DI which are due to insufficient levels of ADH or Anti diuretic hormone. (targetwoman.com)
  • NewsTarget) Diabetes is a disorder where the body is unable to regulate blood sugar levels. (diabetestalk.net)
  • [ 6 ] In the developed world, and increasingly elsewhere, type 2 diabetes is the largest cause of nontraumatic blindness and kidney failure . (thediabeticpharmacist.com)
  • Langerhans cell histiocytosis in a 6-year-old girl with headaches and diabetes insipidus. (pacs.de)
  • In rare cases, central diabetes insipidus is caused by a genetic problem. (medlineplus.gov)
  • If treated, central diabetes insipidus usually does not cause severe problems or result in early death. (medlineplus.gov)
  • Only about 10% of neurosecretory neurons must remain intact to avoid central diabetes insipidus. (diabetestalk.net)
  • Central Diabetes Insipidus: This type of diabetes insipidus is the most common type in humans. (diabetestalk.net)
  • Although all dogs can get diabetes, there seems to be a higher incidence in Beagles, Dachshunds, Miniature Schnauzers and Poodles. (diabetestalk.net)
  • PMH-Type II diabetes mellitus (DM) with peripheral neuropathy x 20 years. (nursingassignmentsexpert.com)
  • Diabetes herbal treatment along with the type 1 and type 2 diabetes already have published in my blog under the title successful diabetes treatment naturally at home. (diabetestalk.net)
  • Type of Diabetes Insipidus Diabetes Insipidus (DI) has two types are given below with description: 1. (diabetestalk.net)
  • The first and most common type is diabetes mellitus, quite similar to its human counterpart. (diabetestalk.net)
  • The son became concerned when she forgot her son s name, so he thought he better bring her to the clinic.PMH-Type II diabetes mellitus (DM) with peripheral neuropathy x 20 years. (mynursingessay.com)
  • This is a different condition from type 1 or type 2 diabetes. (decadethirty.com)
  • In addition to being a risk factor for type 2 diabetes , hyperinsulinism due to insulin resistance may increase blood pressure and contribute to hypertension by direct action on vascular endothelial cells (the cells lining blood vessels). (ipfs.io)
  • Obesity is thought to be the primary cause of type 2 diabetes in people who are genetically predisposed to the disease. (thediabeticpharmacist.com)
  • Type 2 diabetes is initially managed by increasing exercise and dietary modification . (thediabeticpharmacist.com)
  • People with type 2 diabetes mellitus may rarely present with nonketotic hyperosmolar coma (a condition of very high blood sugar associated with a decreased level of consciousness and low blood pressure ). (thediabeticpharmacist.com)
  • The development of type 2 diabetes is caused by a combination of lifestyle and genetic factors. (thediabeticpharmacist.com)
  • [ 6 ] A lack of sleep has been linked to type 2 diabetes. (thediabeticpharmacist.com)
  • Diabetes is a condition characterized by an excess buildup of sugar in the body. (diabetesprohelp.com)